1156658

Sebela Pharmaceuticals Inc — FEI 3011068578

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 3, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Roswell, GA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)